2017 San Antonio Breast Cancer Symposium Coverage
Every December, the San Antonio Breast Cancer Symposium brings together clinicians, researchers, and advocates to discuss the latest breast cancer study results. We’re proud to present our coverage below. We’ll be adding updates and links to the top of this page.
Research News
Study Suggests Intensifying Chemotherapy Improves Outcomes for Women With Early-Stage Disease, Jan. 10, 2018
Very Early Study Hints That Keytruda May Offer Benefits for Certain Metastatic HER2-Positive Breast Cancers, Jan. 9, 2018
Younger Women Report High Rate of Arm Problems 1 Year After Breast Cancer Diagnosis, Jan. 4, 2018
Extending Aromatase Inhibitor Treatment for 5 More Years No Better Than 2 More Years, Jan. 3, 2018
Temporary Ovarian Suppression May Help Preserve Fertility During Chemotherapy, Jan. 2, 2018
Acupuncture Eases Joint Pain Caused by Aromatase Inhibitors Dec. 21, 2017
Experimental Talazoparib Seems Better Than Chemotherapy for Metastatic HER2-Negative Disease in Women With a BRCA Mutation, Dec. 20, 2017
Kisqali Can Help Treat Younger Women With Metastatic Hormone-Receptor-Positive Disease, Dec. 19, 2017
Overweight Postmenopausal Women Who Lose Modest Amount of Weight Have Lower Breast Cancer Risk, Dec. 16, 2017
Podcasts
Ovarian Suppression Can Help Protect Ovarian Function and May Preserve Fertility in Younger Women Being Treated with Chemotherapy
Matteo Lambertini, M.D.
Acupuncture Helps Ease Joint Pain Caused by Aromatase Inhibitors
Dawn Hershman, M.D.
Experimental Talazoparib Seems Better Than Chemotherapy for Metastatic HER2-Negative Disease in Women With a BRCA Mutation
Jennifer Litton, M.D.
Postmenopausal Women Who Lose Modest Amount of Weight Have Lower Breast Cancer Risk
Rowan Chlebowski, M.D., Ph.D.
The Serenity Project: This Is Metastatic Breast Cancer -- Heard in the Halls: Voices From the 2017 San Antonio Breast Cancer Symposium
Kelly Shanahan, M.D.
Where Are We With Immunotherapy to Treat Breast Cancer? -- Heard in the Halls: Voices From the 2017 San Antonio Breast Cancer Symposium
Leisha Emens, M.D., Ph.D.
Can we help guide you?
Create a profile for better recommendations
-
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
-
Breast Self-Exam
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
-
Triple-Negative Breast Cancer
Triple-negative breast cancer is cancer that tests negative for estrogen receptors, progesterone...
